In a surprising turn of events, Ginkgo Bioworks, the once flourishing biotech company, has announced a downsizing of its operations in the Boston real...
**New Biotech Firm Raises $300 Million with Focus on Heart Disease**In a bold move that has sent shockwaves through the biotech industry, MyoKardia's former...